Trial intelligence / Profile preview

Clevudine vs Tenofovir vs Combination in HBeAg Negative Chronic Hepatitis B

NCT00823342Phase 3Terminated

Sponsor
ANRS
Start
Dec 2008
Primary completion
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of clevudine in Chronic Hepatitis B (CHB), sponsored by ANRS. Started Dec 2008; status: terminated.

02

Drugs

clevudine
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on NCT00823342.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00823342.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call